DCAF11-dependent molecular glue degrader activated by glutathionylation
Coverage (5)
- Dana-Farber team develops degrader platform, discovers first metabolically activated molecular glue Bioengineer.org · 3d ago
- Protein Degradation Screen Reveals Tunable Molecular Glue Activity Technology Networks · 3d ago
- New molecular glue platform broadens E3 ligase targeting for cancer drug development Drug Target Review · 3d ago
- Dana-Farber Builds a Search Engine for Drugs That Destroy Proteins Instead of Blocking Them Medical Daily · 3d ago
- DCAF11-dependent molecular glue degrader activated by glutathionylation Nature · 3d ago broke it first
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
Why cyclospora keeps showing up in produce season after season
Utah reports nearly 50 cyclosporiasis cases, prompting local farmers to emphasize the importance of local produce.
Everyone's talking about hormone therapy for menopause. Should I be on it?
Hormone replacement therapy use has nearly doubled since 2017 amid new guidelines and widespread public discussion.
FDA approves 1st mRNA flu shot, from Moderna
The first mRNA-based influenza vaccine has received federal approval in the United States.
DNR Closes Additional Areas of Cunningham Falls State Park Following Second Beaver Attack
Two separate beaver attacks at Cunningham Falls State Park prompt additional closures in Maryland.
GLP-1 Drugs May Have a Hidden Effect on Your Eyes, Study Finds
New safety guidance and a lawsuit spotlight a possible eye‑risk link in popular GLP-1 weight‑loss drugs.
Pesticide exposure linked to higher risk of ALS, research finds
New research links occupational pesticide exposure to a significantly heightened risk of motor neuron diseases like ALS.